LYKA LABS
|
The Current P/B Ratio of LYKA LABS is 9.57.
Share Price | ₹158.4 | Dec 30,2024 |
Market Cap | ₹565.5 Cr | |
Book Value | ₹59.1 Cr | Mar2024 - Consolidated Results |
Price/Book | 9.57x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of LYKA LABS
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹565.5 Cr] as on Dec 30,2024
(/) Book Value [ ₹59.1 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 9.57x ]
Thus, for LYKA LABS , the investors are currently willing to pay '9.57 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of LYKA LABS !
The chart below summarizes the trend in P/B Ratio of LYKA LABS over the last five years.
Historical PB (Price/Book ) ratio chart of LYKA LABS
PB Ratio Performance Analysis for LYKA LABS
- LYKA LABS 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.23x.
- LYKA LABS 's operated at median p/b ratio of 5.93x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LYKA LABS 's p/b ratio peaked in Mar2022 at 29.17x.
- LYKA LABS 's p/b ratio hit its five-year low in Mar2021 of -2.89x.
How does LYKA LABS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
LYKA LABS | 59.09 | 9.57 | 565.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 7.09 | 451,603.0 |
CIPLA LTD | 26,619.90 | 4.61 | 122,810.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 4.09 | 114,946.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.86 | 96,377.1 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.85 | 160,862.0 |
MANKIND PHARMA LTD | 9,339.84 | 12.61 | 117,798.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 16.64 | 114,120.0 |
LUPIN LTD | 14,175.80 | 7.43 | 105,374.0 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.53 | 75,521.6 |
ABBOTT INDIA LTD | 3,658.73 | 17.30 | 63,304.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs LYKA LABS 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.53x |
Max industry PB | 17.30x |
Median industry PB | 7.43x |
Average industry PB | 8.96x |
You may also like the below Video Courses